Momenta Pharmaceuticals to Present at Stanford Group Company 13th Annual Healthcare...

Momenta Pharmaceuticals to Present at Stanford Group Company 13th Annual
Healthcare Conference

CAMBRIDGE, Mass., Jan. 15, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals,
Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization
and engineering of complex drugs, today announced that Richard Shea, Chief
Financial Officer, will deliver a corporate presentation at the Stanford Group
Company 13th Annual Healthcare Conference on Thursday, January 17th at 10:30
a.m. EST. The conference will be held at The Four Seasons Hotel in Washington,
D.C.

A live audio webcast of each presentation will available on the "Investors"
section of the Company's website located at www.momentapharma.com. A replay of
the presentation will be posted on the Momenta website approximately thirty
minutes after the event and will be available through February 16th, 2008.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed
structural analysis of complex mixture drugs. Momenta is applying its technology
to the development of generic versions of complex drug products, as well as to
the discovery and development of novel drugs. The Company's most advanced
product candidate, M-Enoxaparin is designed to be a technology-enabled generic
version of Lovenox(r). Momenta's first novel drug candidate is M118, a
rationally engineered anticoagulant specifically designed for acute coronary
syndromes. Within the Company's discovery program, it is seeking to discover and
develop novel therapeutics by applying its technology to better understand
sugars' functions in biological processes, with an initial focus in oncology.
Momenta was founded in 2001 based on technology initially developed at
Massachusetts Institute of Technology and is headquartered in Cambridge, MA.

To receive additional information about Momenta, please visit the website at
www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta
Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are
property of their respective owners.

-0-
CONTACT: Momenta Pharmaceuticals, Inc.
Investor Relations
Beverly Holley
617-395-5189